Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO, Director
-
Issuer Symbol
-
HCA on NYSE
SAMUEL N. HAZEN - trading volume in the past year for HCA Healthcare, Inc.
Holdings reported by SAMUEL N. HAZEN for HCA Healthcare, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
813,320 |
$389,840,542 |
$479.32 |
10 Feb 2026 |
By LP |
|
|
| Common Stock |
200,000 |
$95,864,000 |
$479.32 |
10 Feb 2026 |
By 2025 GRAT |
|
|
| Common Stock |
178,289 |
$85,457,483 |
$479.32 |
10 Feb 2026 |
By 2024 GRAT |
|
|
| Common Stock |
93,088 |
$44,618,940 |
$479.32 |
10 Feb 2026 |
By 2023 Trust |
|
|
| Common Stock |
64,842 |
$32,553,926 |
$502.05 |
10 Feb 2026 |
Direct |
|
|
| Common Stock |
16,731 |
$8,019,502 |
$479.32 |
10 Feb 2026 |
By 2023 GST Trust |
|
|
| Common Stock |
16,024 |
$7,680,623 |
$479.32 |
10 Feb 2026 |
By HD Trust |
|
|
| Stock Appreciation Right |
0 |
|
|
30 Jan 2026 |
Direct |
Common Stock |
|
Transactions reported by SAMUEL N. HAZEN for HCA Healthcare, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.